1. Home
  2. FOXX vs CTSO Comparison

FOXX vs CTSO Comparison

Compare FOXX & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$5.79

Market Cap

34.0M

Sector

N/A

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.62

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
CTSO
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
37.0M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
FOXX
CTSO
Price
$5.79
$0.62
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
11.0K
105.8K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$12.21
Revenue Next Year
N/A
$20.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.71
$0.50
52 Week High
$8.70
$1.39

Technical Indicators

Market Signals
Indicator
FOXX
CTSO
Relative Strength Index (RSI) 67.81 48.48
Support Level $3.87 $0.62
Resistance Level $5.95 $0.74
Average True Range (ATR) 0.54 0.07
MACD 0.20 -0.00
Stochastic Oscillator 89.74 54.70

Price Performance

Historical Comparison
FOXX
CTSO

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: